ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 42 filers reported holding ONCOMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,000 | +33.3% | 15,592 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $12,000 | -63.6% | 15,592 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $33,000 | -8.3% | 15,592 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $36,000 | -28.0% | 15,592 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $50,000 | -21.9% | 15,592 | 0.0% | 0.00% | -20.0% |
| Q4 2017 | $64,000 | -44.8% | 15,592 | -39.1% | 0.01% | -37.5% |
| Q3 2017 | $116,000 | +251.5% | 25,592 | +155.9% | 0.01% | +300.0% |
| Q2 2017 | $33,000 | -64.1% | 10,000 | 0.0% | 0.00% | -60.0% |
| Q1 2017 | $92,000 | -52.3% | 10,000 | -60.0% | 0.01% | -44.4% |
| Q4 2016 | $193,000 | -51.8% | 25,000 | -28.6% | 0.01% | -52.6% |
| Q3 2016 | $400,000 | -7.2% | 35,000 | 0.0% | 0.02% | -9.5% |
| Q2 2016 | $431,000 | -22.5% | 35,000 | -36.4% | 0.02% | -19.2% |
| Q1 2016 | $556,000 | -29.5% | 55,000 | +57.1% | 0.03% | -21.2% |
| Q4 2015 | $789,000 | +35.8% | 35,000 | 0.0% | 0.03% | +37.5% |
| Q3 2015 | $581,000 | +3.4% | 35,000 | +40.0% | 0.02% | +20.0% |
| Q2 2015 | $562,000 | +8.9% | 25,000 | +25.0% | 0.02% | 0.0% |
| Q1 2015 | $516,000 | +58.3% | 20,000 | +33.3% | 0.02% | +53.8% |
| Q4 2014 | $326,000 | +14.8% | 15,000 | 0.0% | 0.01% | +8.3% |
| Q3 2014 | $284,000 | -18.6% | 15,000 | 0.0% | 0.01% | -25.0% |
| Q2 2014 | $349,000 | -30.9% | 15,000 | 0.0% | 0.02% | -46.7% |
| Q1 2014 | $505,000 | +14.0% | 15,000 | 0.0% | 0.03% | -6.2% |
| Q4 2013 | $443,000 | +140.8% | 15,000 | +25.0% | 0.03% | +100.0% |
| Q3 2013 | $184,000 | – | 12,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|